Aspirin Cuts Risk Of Death From Prostate Cancer 39 Percent

For men with slow-growing prostate cancer, three aspirin a week can reduce the risk of developing lethal cancer by 34 percent, and the risk of dying of prostate cancer by 39 percent. That’s the finding of a new analysis from the long-running Physicians’ Health Study, a longitudinal trial at Brigham and Women’s Hospital in Boston and the Harvard T.H. Chan School of Public Health. The Wall Street Journal reports that 99 percent of men with slow growing cancer are alive after five years, and 98 percent are alive after a decade, but once the tumor spreads other parts of the body, five-year survival falls to 28 percent. The paper reports that aspirin had little effect on the overall incidence of prostate cancer, but did appear to slow the progression of the disease.